One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A Call to Action to Eliminate Indoor Tanning
Carolyn J. Heckman, PhD1; David B. Buller, PhD2; Jerod L. Stapleton, PhD3
doi : 10.1001/jamadermatol.2021.0874
JAMA Dermatol. 2021;157(7):767-768
Two Trajectories to Melanoma on the Hands and Feet
A. Hunter Shain, PhD1
doi : 10.1001/jamadermatol.2021.0792
JAMA Dermatol. 2021;157(7):769-770
Dermatology Advances Into an Era of Precision Medicine
Jennifer Y. Wang, MD1; Kavita Y. Sarin, MD, PhD1
doi : 10.1001/jamadermatol.2021.0024
JAMA Dermatol. 2021;157(7):770-772
Assessment of Diagnostic Strategy for Mucous Membrane Pemphigoid
Hanan Rashid, MD1; Joost M. Meijer, MD, PhD1; Gilles F. H. Diercks, MD, PhD2; Nini E. Sieben, MD1; Maria C. Bolling, MD, PhD1; Hendri H. Pas, PhD1; Barbara Horvath, MD, PhD1
doi : 10.1001/jamadermatol.2021.1036
JAMA Dermatol. 2021;157(7):780-787
An accurate diagnosis of mucous membrane pemphigoid (MMP) is essential to reduce diagnostic and therapeutic delay.
Evaluation of Topical Corticosteroid Use in Pregnancy and Risk of Newborns Being Small for Gestational Age and Having Low Birth Weight
Niklas Worm Andersson, MD1,2,3; Lone Skov, MD, PhD3,4; Jon Trærup Andersen, MD, PhD2,4
doi : 10.1001/jamadermatol.2021.1090
JAMA Dermatol. 2021;157(7):788-795
Topical corticosteroids are frequently used during pregnancy. Limited data have raised concerns about an increased risk of the newborn being small for gestational age (SGA) and having low birth weight, in particular with use of potent to very potent agents during pregnancy.
Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis
Erik Hedman-Lagerlöf, PhD1; Jens Fust, MSc1; Erland Axelsson, PhD1; Marianne Bonnert, PhD1,2; Maria Lalouni, PhD1; Olof Molander, MSc1; Petter Agrell, MSc1; Anna Bergman, MSc1; Nils Lindefors, MD, PhD1; Maria Bradley, MD3
doi : 10.1001/jamadermatol.2021.1450
JAMA Dermatol. 2021;157(7):796-804
Atopic dermatitis is a common and debilitating skin condition characterized by intense itching and chronic inflammation. Research on behavioral treatments with high accessibility is needed.
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases
Maria C. Schneeweiss, MD1,2,3; Seoyoung C. Kim, MD, ScD1,2,4; Richard Wyss, PhD1,2; Yinzhu Jin, MD1; Kristyn Chin, BS1; Joseph F. Merola, MD, MMSc2,3,4; Arash Mostaghimi, MD, MPA, MPH2,3,5; Jonathan I. Silverberg, MD, PhD, MPH6; Sebastian Schneeweiss, MD, ScD1,2
doi : 10.1001/jamadermatol.2021.1570
JAMA Dermatol. 2021;157(7):805-816
Several studies have linked chronic inflammatory skin diseases (CISDs) with venous thromboembolism (VTE) in a range of data sources with mixed conclusions.
Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms
John S. Barbieri, MD, MBA1; Misha Rosenbach, MD1,2; Olaf Rodriguez, MD1; David J. Margolis, MD, PhD1,3
doi : 10.1001/jamadermatol.2021.1805
JAMA Dermatol. 2021;157(7):817-823
Although granuloma annulare (GA) has been associated with several other conditions, these studies have been limited by single-center designs and small sample sizes.
Incidence and Prevalence of Granuloma Annulare in the United States
John S. Barbieri, MD, MBA1; Olaf Rodriguez, MD1; Misha Rosenbach, MD1,2; David Margolis, MD, PhD1,3
doi : 10.1001/jamadermatol.2021.1847
JAMA Dermatol. 2021;157(7):824-830
Although several single-center studies have estimated that granuloma annulare may account for approximately 0.1% to 0.4% of new patients presenting to dermatologists, large-scale population-based studies estimating the prevalence and incidence of granuloma annulare are lacking.
A Mutational Survey of Acral Nevi
Keiran S. M. Smalley, PhD1,2; Jamie K. Teer, PhD3; Y. Ann Chen, PhD3; Jheng-Yu Wu, PhD1; Jiqiang Yao, PhD4; John M. Koomen, PhD5; Wei-Shen Chen, MD6; Paul Rodriguez-Waitkus, MD6; Florian A. Karreth, PhD5; Jane L. Messina, MD2
doi : 10.1001/jamadermatol.2021.0793
JAMA Dermatol. 2021;157(7):831-835
Acral skin may develop nevi, but their mutational status and association with acral melanoma is unclear.
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi
Susan J. Robertson, MBBS1,2; Lisa Orme, MBBS3,4; Rodrigo Teixeira, MD5,6; Maryam Shamassi, MD7; Felicity Newell, PhD8; Ann-Marie Patch, PhD8; Iwei Yeh, MD, PhD9; Grace Gard, MBBS10; James Wilmott, PhD11; Louise Jackett, MBBS (Hons)11,12,13; Philip LeBoit, MD9; Andrew Fellowes, PhD4; Grant MacArthur, PhD4; Stephen Fox, DPhil4; Nicholas K. Hayward, PhD8; Boris Bastian, MD, PhD9; Richard Scolyer, MD11,12,13; Nicola Waddell, PhD8; Anthony Penington, MD2,5,6; Mark Shackleton, PhD4,10,14
doi : 10.1001/jamadermatol.2021.0025
JAMA Dermatol. 2021;157(7):836-841
Spitz nevi are benign melanocytic neoplasms that classically present in childhood. Isolated Spitz nevi have been associated with oncogenic gene fusions in approximately 50% of cases. The rare agminated variant of Spitz nevi, thought to arise from cutaneous genetic mosaicism, is characterized by development of clusters of multiple lesions in a segmental distribution, which can complicate surgical removal. Somatic single-nucleotide variants in the HRAS oncogene have been described in agminated Spitz nevi, most of which were associated with an underlying nevus spilus. The use of targeted medical therapy for agminated Spitz nevi is not well understood.
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency
Bridget E. Shields, MD1,2; Ludmila Perelygina, PhD3; Sara Samimi, MD4; Paul Haun, MD4; Thomas Leung, MD, PhD4; Emily Abernathy, MS3; Min-hsin Chen, PhD3; LiJuan Hao, MD3; Joseph Icenogle, PhD3; Beth Drolet, MD1; Barbara Wilson, MD5; Joshua S. Bryer, BA4; Ross England, MD, PhD6; Emily Blumberg, MD6; Karolyn A. Wanat, MD5,7; Kathleen Sullivan, MD, PhD8,9; Misha Rosenbach, MD4
doi : 10.1001/jamadermatol.2021.1577
JAMA Dermatol. 2021;157(7):842-847
Immunodeficiency-related, vaccine-derived rubella virus (RuV) as an antigenic trigger of cutaneous and visceral granulomas is a rare, recently described phenomenon in children and young adults treated with immunosuppressant agents.
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis
Michael Hughes, PhD1; Yannick Allanore, PhD2; Khadija El Aoufy, MSc3; Christopher P. Denton, PhD4; Dinesh Khanna, MD5; Thomas Krieg, PhD6; Marco Matucci-Cerinic, PhD3
doi : 10.1001/jamadermatol.2021.1463
JAMA Dermatol. 2021;157(7):851-858
Digital ulcers (DUs) occurring on the fingers in patients with systemic sclerosis (SSc) are associated with substantial pain and disability and are often challenging to treat. However, careful clinical assessment and prompt intervention (wound bed management and systemic pharmacologic treatment) may modify the clinical course.
Rupioid Psoriasis
Ken Hiu-Kan Ip, MBChB1; Harriet Sara Cheng, MBChB, MMed1,2; Fergus G. Oliver, MBChB1
doi : 10.1001/jamadermatol.2021.0451
JAMA Dermatol. 2021;157(7):859
Secondary Anetoderma
Myrian de Faria Melo, MD1; Isabela de Faria Melo2; Gabriela Fortes Escobar, MD, MSc1
doi : 10.1001/jamadermatol.2021.0440
JAMA Dermatol. 2021;157(7):860
Purpuric Edematous Nodules and Plaques in an Immunosuppressed Older Man
Arianna F. Yanes, MD1; Matthew L. Hedberg, MD, PhD1; Jules B. Lipoff, MD1
doi : 10.1001/jamadermatol.2021.1207
JAMA Dermatol. 2021;157(7):866-867
Pruritic Lichenified Plaques on the Legs of a Man
Eva M. Sánchez-Martínez, MD1; Nohelia Rojas-Ferrer, MD2; Almudena Mateu-Puchades, MD1
doi : 10.1001/jamadermatol.2021.1785
JAMA Dermatol. 2021;157(7):868-869
Skin Cancer Telemedicine Medical Malpractice Risk
Alexander L. Fogel, MD, MBA1; Nathaniel M. Lacktman, JD2; Joseph C. Kvedar, MD3
doi : 10.1001/jamadermatol.2021.1475
JAMA Dermatol. 2021;157(7):870-871
Dermatologists’ Perspectives on Artificial Intelligence and Augmented Intelligence?—?A Cross-sectional Survey
Caroline A. Nelson, MD1; Swapna Pachauri, MPH2; Rosie Balk, MA2; Jeffrey Miller, PhD2; Rushan Theunis, MS2; Justin M. Ko, MD, MBA3; Carrie L. Kovarik, MD4,5
doi : 10.1001/jamadermatol.2021.1685
JAMA Dermatol. 2021;157(7):871-874
Barriers to Physician-Based Skin Examinations for Adolescent and Young Adult Survivors of Melanoma in the Project Forward Study
Katherine Y. Wojcik, PhD1,2,3; Kimberly A. Miller, PhD3,4; Ashley Wysong, MD5; Ann S. Hamilton, PhD3; Michael R. Cousineau, PhD3; Myles G. Cockburn, PhD3,4; Joel E. Milam, PhD3,6
doi : 10.1001/jamadermatol.2021.1850
JAMA Dermatol. 2021;157(7):874-876
Cost of Treatment of Benign and Premalignant Lesions During Skin Cancer Screening
Alyce Anderson, MD, PhD1; Martha Matsumoto, MD, MS2; Aaron Secrest, MD, PhD3; Melissa I. Saul, MS4; Jonhan Ho, MD, MS2; Laura K. Ferris, MD, PhD2
doi : 10.1001/jamadermatol.2021.1953
JAMA Dermatol. 2021;157(7):876-879
Treatment of Chronic Pruritus With Medical Marijuana
Youkyung S. Roh, BA1; Nishadh Sutaria, BS1; Natalia Fontecilla Biles, MD1; Shawn G. Kwatra, MD1
doi : 10.1001/jamadermatol.2021.1194
JAMA Dermatol. 2021;157(7):879-880
Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus
Daniel R. Mazori, MD1; Michelle S. Min, MD, MS1; Bina Kassamali, BA1; Lars Brichta, PharmD, PhD2; Joseph F. Merola, MD, MMSc1,3; Ruth Ann Vleugels, MD, MPH, MBA1; Avery H. LaChance, MD, MPH1
doi : 10.1001/jamadermatol.2021.1198
JAMA Dermatol. 2021;157(7):880-882
